Belgium's UCB is riding high today after it won the FDA nod for a new indication for Cimzia as a rheumatoid arthritis remedy. Company officials and some analysts said the drug could be an up-and-coming blockbuster. Report [1]
Links:
[1] http://www.fiercebiotech.com/story/ucb-shares-jump-fdas-approval-cimzia/2009-05-14